363208783 | rmh | 37795533 | | 7536963 | 3/28/2007 12:00:00 am | same | | dis | admission date: 1/10/2007 report status:discharge date: 3/20/2007 final discharge orders castiola , lloyd 804-00-14-8aa west ine , kentuckyservice: vasdischarge patient on: 9/15/07 at 01:00 pmcontingent upon not applicablewill d/c order be used as the d/c summary: yesattending: humber , sydney johnson , m.d.code status:full codedisposition: rehabilitationmedications on admission:1. acetylsalicylic acid 81 mg po qd2. albuterol inhaler 2 puff inh qid3. calcitriol 0.25 mcg po qd4. clopidogrel 75 mg po qd5. docusate sodium 100 mg po bid6. folic acid 1 mg po qd7. furosemide 10 mg po qd8. gabapentin 100 mg po tid9. ipratropium inhaler 2 puff inh qid10. lisinopril 2.5 mg po qd11. metoprolol succinate extended release 50 mg po qd12. niferex 150 150 mg po bid13. omeprazole 20 mg po qd14. oxycodone 10 mg po q4hmedications on discharge:plavix ( clopidogrel ) 75 mg po dailytylenol ( acetaminophen ) 650 mg po q4h prn headacheacetylsalicylic acid 81 mg po dailyduoneb ( albuterol and ipratropium nebulizer )3/0.5 mg neb q6hduoneb ( albuterol and ipratropium nebulizer )3/0.5 mg neb q6h prn shortness of breath , wheezingalbuterol inhaler 2 puff inh qid prn wheezingcolace ( docusate sodium ) 100 mg po bidfolate ( folic acid ) 1 mg po dailylasix ( furosemide ) 10 mg po dailyneurontin ( gabapentin ) 100 mg po tidheparin 5 , 000 units sc q8hinsulin regular humansliding scale ( subcutaneously ) sc ac+hs low scalecall ho if bs less than 60if bs is less than 125 , then do not administersupplemental ( sliding scale ) insulinif bs is 125-150 , then give 0 units subcutaneouslyif bs is 151-200 , then give 1 units subcutaneouslyif bs is 201-250 , then give 2 units subcutaneouslyif bs is 251-300 , then give 3 units subcutaneouslyif bs is 301-350 , then give 4 units subcutaneouslyif bs is 351-400 , then give 5 units subcutaneouslycall ho if bs is greater than 350if receiving standing regular insulin , please give at sametime and in addition to standing regular insulinlisinopril 2.5 mg po dailymaalox-tablets quick dissolve/chewable 1-2 tab po q6hprn upset stomachmilk of magnesia ( magnesium hydroxide )30 milliliters po daily prn constipationlopressor ( metoprolol tartrate ) 25 mg po tidhold if: sbp < 95 or hr < 65food/drug interaction instructiontake consistently with meals or on empty stomach.omeprazole 20 mg po dailyoxycodone 5-10 mg po q3h prn painmultivitamin therapeutic ( therapeutic multivi... )1 tab po dailydiet: house / ada 1800 cals/dyreturn to work: not applicablefollow up appointment( s ):dr. pherguson , 317-001-4753 1 week ,primary care physician please call to make appt ,allergy: nkaadmit diagnosis:non-healing left foot woundprincipal discharge diagnosis ;responsible after study for causing admission )sameother diagnosis;conditions , infections , complications , affecting treatment/stayhypertension ( hypertension ) pernicious anemia ( pernicious anemia )copd ( chronic obstructive pulmonary disease ) pneumonia( pneumonia ) cri ( chronic renal dysfunction )operations and procedures:7/28/07 engwall , tyrell chi , m.d.debridement lt footother treatments/procedures ( not in o.r. )none.brief resume of hospital course:patient was admitted to thickua medical center surgery service on3/28/2007 for preoperative evaluation/clearance. on 4/14 she wastaken to the operating room where she underwent debridement of hernon-healing left tma site no concerning intraoperative events occurred;please see dictated operative note for details. in the pacu she wasnoted to be oozing from several points within the wound bed. two silkstitches were placed with improved hemostasis. on pod 1 , the oozingcontinued and her hct had dropped to 21. she remained hemodynamicallystable but given her cardiovascular history she was transfused a total of4 units of blood over the next 2 hospital days. surgicell was also placedinto the wound bed with adequate hemostasis. the remainder of herhospital course was unremarkable. patient had adequate pain control andwas tolerating sips on pod0 and was advanced to regular diet by pod1.she remained neurologically intact postoperatively. her blood pressureremained at baseline ( sbp 110-140s ). she was kept on perioperativevanc/levo/flagyl throughout her hospitalization. on pod 4 , she wasdischarged to rehab in stable condition , afebrile , voiding independently ,with adequate pain control. her wound had areas of granulation; willplan to continue wet-to-dry dressings with normal saline for gentledebridement. will reevaluate for vac dressing and possible eventual skingraft closure on follow up. she was given explicit instructions tofollow-up in clinic with dr. foderaro in 1 week.additional comments: additional comments: if you experience fever , increasing pain ,redness/drainage from your foot , chest pain , shortness ofbreath or other concerning symptoms , please seek medical attentionimmediately-resume medications as prescribed-rehab should continue with wet to dry dressings with normal saline to ltma wound bid.-activity: touch down weight bearing left leg-anticoagulation:please continue aspirin and plavix-please schedule and attend follow-up appointment with dr. vattikuti in1-2 weeksdischarge condition: stableto do/plan:please see above instructions/planno dictated summaryentered by: beaven , tom v. , m.d. ( le64 ) 9/15/07 @ 08:08 am end of discharge orders